The role of the tumour microenvironment in immunotherapy

被引:74
作者
Gasser, Stephan [1 ,2 ]
Lim, Lina H. K. [3 ]
Cheung, Florence S. G. [3 ]
机构
[1] Roche Glycart AG, Roche Innovat Ctr Zurich, Roche Pharma Res & Early Dev, Schlieren, Switzerland
[2] Natl Univ Singapore, Ctr Life Sci, NUS Immunol Programme, Yong Loo Lin Sch Med,Dept Microbiol & Immunol, Singapore, Singapore
[3] Natl Univ Singapore, Ctr Life Sci, NUS Immunol Programme, Yong Loo Lin Sch Med,Dept Physiol, Singapore, Singapore
关键词
pancreatic cancer; thyroid cancer; immunotherapy; tumour microenvironment; endometrial cancer; PAPILLARY THYROID-CANCER; PANCREATIC DUCTAL ADENOCARCINOMA; TOLL-LIKE RECEPTOR-3; REGULATORY T-CELLS; ADRENOCORTICAL CARCINOMA; MEMBRANE ANTIGEN; NK CELLS; CHECKPOINT BLOCKADE; ANTITUMOR-ACTIVITY; CROSS-PRESENTATION;
D O I
10.1530/ERC-17-0146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent success in immunomodulating strategies in lung cancer and melanoma has prompted much enthusiasm in their potential to treat other advanced solid malignancies. However, their applications have shown variable success and are even ineffective against some tumours. The efficiency of immunotherapies relies on an immunogenic tumour microenvironment. The current field of cancer immunology has focused on understanding the interaction of cancer and host immune cells to break the state of immune tolerance and explain how molecular patterns of cytokines and chemokines affect tumour progression. Here, we review our current knowledge of how inherent properties of tumours and their different tumour microenvironments affect therapeutic outcome. We also discuss insights into recent multimodal therapeutic approaches that target tumour immune evasion and suppression to restore anti-tumour immunity.
引用
收藏
页码:T283 / T295
页数:13
相关论文
共 107 条
[1]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[2]  
[Anonymous], IMMUNOTHERAPY
[3]   Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1 [J].
Arnold, James N. ;
Magiera, Lukasz ;
Kraman, Matthew ;
Fearon, Douglas T. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :121-126
[4]   Emerging therapy for adrenocortical carcinoma [J].
Aufforth, Rachel D. ;
Nilubol, Naris .
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2014, 1 (02) :173-182
[5]   PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy [J].
Azad, Abul ;
Lim, Su Yin ;
D'Costa, Zenobia ;
Jones, Keaton ;
Diana, Angela ;
Sansom, Owen J. ;
Kruger, Philipp ;
Liu, Stanley ;
McKenna, W. Gillies ;
Dushek, Omer ;
Muschel, Ruth J. ;
Fokas, Emmanouil .
EMBO MOLECULAR MEDICINE, 2017, 9 (02) :167-180
[6]   Recent progress in adjuvant discovery for peptide-based subunit vaccines [J].
Azmi, Fazren ;
Fuaad, Abdullah Al Hadi Ahmad ;
Skwarczynski, Mariusz ;
Toth, Istvan .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (03) :778-796
[7]   Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma [J].
Bailey, Peter ;
Chang, David K. ;
Forget, Marie-Andree ;
San Lucas, Francis A. ;
Alvarez, Hector A. ;
Haymaker, Cara ;
Chattopadhyay, Chandrani ;
Kim, Sun-Hee ;
Ekmekcioglu, Suhendan ;
Grimm, Elizabeth A. ;
Biankin, Andrew V. ;
Hwu, Patrick ;
Maitra, Anirban ;
Roszik, Jason .
SCIENTIFIC REPORTS, 2016, 6
[8]   Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages [J].
Beatty, Gregory L. ;
Winograd, Rafael ;
Evans, Rebecca A. ;
Long, Kristen B. ;
Luque, Santiago L. ;
Lee, Jae W. ;
Clendenin, Cynthia ;
Gladney, Whitney L. ;
Knoblock, Dawson M. ;
Guirnalda, Patrick D. ;
Vonderheide, Robert H. .
GASTROENTEROLOGY, 2015, 149 (01) :201-210
[9]   Adrenocortical Carcinoma in the United States Treatment Utilization and Prognostic Factors [J].
Bilimoria, Karl Y. ;
Shen, Wen T. ;
Elaraj, Dina ;
Bentrern, David J. ;
Winchester, David J. ;
Kebebew, Electron ;
Sturgeon, Cord .
CANCER, 2008, 113 (11) :3130-3136
[10]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465